|Twenty-nine adult dogs were included in a blinded, multicenter, prospective clinical trial with membranous (n = 16) and membranoproliferative (n = 13).
Dogs were randomly assigned to receive either EN (0.5 mg/kg PO q12-24h; n = 16) or placebo (n = 14) for 6 months (1 dog was treated first with the placebo and then with EN). All dogs were treated with low-dose aspirin (0.5-5 mg/kg PO q12-24h) and fed a commercial diet. At baseline, serum creatinine (SrCr), systolic blood pressure (SBP), and glomerular histologic grade were not different between groups, but the urine protein/creatinine ratio (UP/C) was greater in the EN group compared with the placebo group (8.7 +/- 4.4 versus 4.7 +/- 2.3).
After 6 months of treatment, the change in UP/C from baseline was significantly different between groups (EN = -4.2 +/- 1.4 versus 1.9 +/- 0.9 in the placebo group). When data were adjusted for changes in SrCr (SrCr X UP/C) a similar significant reduction was noted ( 2.2 +/- 15.2 versus 8.4 +/- 10.1). The change in SBP after 6 months of treatment also was significantly different between groups (EN = -12.8 +/- 27.3 versus 5.9 +/- 21.5 mm Hg in the placebo group).
Response to treatment was categorized as improvement (assigned a value of 2), no progression (assigned a value of 1), and progression (assigned a value of 0).
Response was significantly better in the EN group (1.4 +/- 0.8) compared with the placebo group (0.3 +/- 0.5).
These results suggest that EN treatment is beneficial in dogs with naturally occurring idiopathic GN.
Source: Grauer GF,et al (2000): Effects of enalapril versus placebo as a treatment for canine idiopathic glomerulonephritis. In: J Vet Intern Med 2000 Sep-Oct;14(5):526-33
Tell a friend
Send this article
Prevalence of impinged spinous processes in asymptomatic dogsIntraocular pressure curve protocol for use in dogsAtopic dermatitis and the intestinal microbiota in dogs and menBacterial contamination and DNA quantification in stored blood units Atypical chorioretinal coloboma in a Golden RetrieverOral direct factor Xa inhibitor anticoagulant in healthy adult horsesUse of three human cervical fusion implants in the canine cervical vertebral columnRadiotherapy for canine adrenocortical tumours with vascular invasionIntrahepatic portocaval shunt in dogs - diagnosis and therapyRenal Abnormalities in Dogs with CoccidioidomycosisNovel retinopathy in related Gordon settersTolerability of a rapid-escalation vinblastine-prednisolone protocol in canine mast cell tumours